Difficulty: Medium
Average Score: 90%
Practice
What monoclonal antibody is used to prevent respiratory syncytial virus (RSV) in high-risk children?
Correct answer
A
Rationale
The correct answer is A: Palivizumab. Palivizumab is specifically designed to prevent RSV in high-risk children by targeting the virus. Natalizumab is used for multiple sclerosis, Belimumab for lupus, and Eculizumab for paroxysmal nocturnal hemoglobinuria. These choices are incorrect as they do not target RSV.